Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
-
* Corresponding author: Ranjeny Thomas r.thomas1@uq.edu.au
Arthritis Research & Therapy 2009, 11:R39 doi:10.1186/ar2645
No comments have yet been made on this article.